Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA methyltransferase subunit 11-2 pseudogene 4 (TRMT112P4) is classified as a pseudogene, which means it is a non-functional segment of DNA resembling the protein-coding gene TRMT112 (tRNA methyltransferase activator subunit 11-2). Pseudogenes typically arise from duplication or retrotransposition events and acquire disabling mutations so they do not encode active proteins[2]. There is no evidence that TRMT112P4 encodes a protein, is expressed, or plays any known biological or pathogenic role. It is not regarded as a therapeutic target, enzyme, receptor, or any functional biomolecule. The functional gene TRMT112, by contrast, encodes a protein methyltransferase co-factor involved in tRNA and rRNA modification, but TRMT112P4 does not share this activity[1]. Key clarification: There is nothing functionally or therapeutically relevant about TRMT112P4—its designation as a pseudogene means it is not a true molecular target. If you require information on the functional gene (TRMT112), see below: TRMT112 (tRNA methyltransferase activator subunit 11-2): - Molecular classification: Enzyme co-factor (activates methyltransferases) - Biological functions: Catalyzes or enables rRNA and tRNA methylation, protein methylation, histone methylation, and macromolecule metabolism[1]. - Disease roles: Linked to rare syndromes (e.g., Galloway-Mowat, Williams-Beuren)[1]. - Interacting drugs/biomarkers: None specific as a direct drug target[1]. Summary: TRMT112P4 is a non-functional DNA sequence and not a molecular target or therapeutic entity. If your interest is in methyltransferases, you should focus on the functional gene TRMT112 or other related protein-coding genes, not on pseudogene entries like TRMT112P4[1][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase subunit 11-2 pseudogene 4 (TRMT112P4).